MO HB1327

Health benefit plans providing cancer treatment coverage must cover orally administered anticancer medications on a basis no less favorable than intravenously administered or injected anticancer medications

Oral anticancer medications cannot be subject to prior authorization, dollar limits, co-payments, deductibles, or out-of-pocket expenses that differ from intravenous or injected anticancer medications

Health benefit plans cannot reclassify or increase cost-sharing for anticancer medications to achieve compliance; any increases must apply to the majority of comparable medical or pharmaceutical benefits

Plans that limit total cost-sharing to no more than $75 per 30-day supply for oral anticancer medications are considered in compliance, with annual adjustments allowed up to the Consumer Price Index for the Midwest Region

For high deductible health plans, the $75 cost-sharing limit only applies after the covered person's annual deductible is satisfied; effective January 1, 2015